CSL Vifor has been a pioneer in the development of iron-based products and has established itself as the global leader in the treatment of iron deficiency.
Our highly diversified nephrology portfolio continues to expand and it is focused on distinct comorbidities and complications in chronic kidney disease (CKD) patients.
Popular search terms:
Below you can find the list of product inserts
Ferinject® Singapore PI (approved Jan 2022
Maltofer® drops 50mg/ml Singapore PI (approved by H.S.A. on 14 Sep 2020)
Maltofer® film coated tablets 100mg Singapore PI (approved by H.S.A. on Jul 2020)
Maltofer® syrup 50mg/ml Singapore PI (approved by H.S.A. on 21 Sep 2020)
Korsuva® Injection PI (approve by H.S.A. on 25 Aug 2022)
Venofer® Singapore PI (approved 3 Nov 2021)